Return On Equity of iBio, Inc. from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
iBio, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • iBio, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -84%, a 34% increase year-over-year.
  • iBio, Inc. annual Return On Equity for 2025 was -127%, a 13% increase from 2024.
  • iBio, Inc. annual Return On Equity for 2024 was -145%, a 44% increase from 2023.
  • iBio, Inc. annual Return On Equity for 2023 was -260%, a 332% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

iBio, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -84% +43% +34% 01 Jul 2025 30 Sep 2025
Q2 2025 -127% +18% +13% 01 Apr 2025 30 Jun 2025
Q1 2025 -130% +17% +12% 01 Jan 2025 31 Mar 2025
Q4 2024 -99% +99% +50% 01 Oct 2024 31 Dec 2024
Q3 2024 -127% +198% +61% 01 Jul 2024 30 Sep 2024
Q2 2024 -145% +115% +44% 01 Apr 2024 30 Jun 2024
Q1 2024 -148% +58% +28% 01 Jan 2024 31 Mar 2024
Q4 2023 -198% -43% -28% 01 Oct 2023 31 Dec 2023
Q3 2023 -325% -240% -285% 01 Jul 2023 30 Sep 2023
Q2 2023 -260% -200% -332% 01 Apr 2023 30 Jun 2023
Q1 2023 -205% -170% -487% 01 Jan 2023 31 Mar 2023
Q4 2022 -154% -126% -450% 01 Oct 2022 31 Dec 2022
Q3 2022 -84% -61% -261% 01 Jul 2022 30 Sep 2022
Q2 2022 -60% -37% -160% 01 Apr 2022 30 Jun 2022
Q1 2022 -35% -4% -14% 01 Jan 2022 31 Mar 2022
Q4 2021 -28% +10% +27% 01 Oct 2021 31 Dec 2021
Q3 2021 -23% +32% +58% 01 Jul 2021 30 Sep 2021
Q2 2021 -23% +90% +80% 01 Apr 2021 30 Jun 2021
Q1 2021 -31% +1730% +98% 01 Jan 2021 31 Mar 2021
Q4 2020 -39% +944% +96% 01 Oct 2020 31 Dec 2020
Q3 2020 -56% +326% +85% 01 Jul 2020 30 Sep 2020
Q2 2020 -113% +97% +46% 01 Apr 2020 30 Jun 2020
Q1 2020 -1761% -1612% -1086% 01 Jan 2020 31 Mar 2020
Q4 2019 -983% -828% -534% 01 Oct 2019 31 Dec 2019
Q3 2019 -382% -220% -136% 01 Jul 2019 30 Sep 2019
Q2 2019 -210% -23% -13% 01 Apr 2019 30 Jun 2019
Q1 2019 -148% +87% +37% 01 Jan 2019 31 Mar 2019
Q4 2018 -155% +22% +13% 01 Oct 2018 31 Dec 2018
Q3 2018 -162% -27% -20% 01 Jul 2018 30 Sep 2018
Q2 2018 -187% -90% -92% 01 Apr 2018 30 Jun 2018
Q1 2018 -235% -167% -242% 01 Jan 2018 31 Mar 2018
Q4 2017 -178% -121% -214% 01 Oct 2017 31 Dec 2017
Q3 2017 -135% 01 Jul 2017 30 Sep 2017
Q2 2017 -97% 01 Apr 2017 30 Jun 2017
Q1 2017 -69% 01 Jan 2017 31 Mar 2017
Q4 2016 -57% 01 Oct 2016 31 Dec 2016

iBio, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -127% +18% +13% 01 Jul 2024 30 Jun 2025
2024 -145% +115% +44% 01 Jul 2023 30 Jun 2024
2023 -260% -200% -332% 01 Jul 2022 30 Jun 2023
2022 -60% -37% -160% 01 Jul 2021 30 Jun 2022
2021 -23% +90% +80% 01 Jul 2020 30 Jun 2021
2020 -113% +97% +46% 01 Jul 2019 30 Jun 2020
2019 -210% -23% -13% 01 Jul 2018 30 Jun 2019
2018 -187% -90% -92% 01 Jul 2017 30 Jun 2018
2017 -97% 01 Jul 2016 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.